A new method to analyze lipids for better understanding of diseases
Panoptic electrochemical probe for next-generation mass spectrometry based-lipidomics
This study is exploring new technology to better understand fats in our bodies, which play an important role in our health and are connected to diseases like cancer and diabetes, so we can improve how we detect and analyze them for better health insights.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10896970 on NIH RePORTER |
What this research studies
This research focuses on developing advanced technology to analyze lipids, which are crucial for cellular function and are linked to various diseases like cancer, cardiovascular issues, and diabetes. By utilizing microdroplet electrochemical methods, the project aims to improve the detection and analysis of lipid structures and their isomers, which are often overlooked in current diagnostic practices. This innovative approach could lead to better understanding of lipid metabolism and its implications for health. The research will involve sophisticated mass spectrometry techniques to enhance lipid analysis capabilities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to lipid metabolism, such as cancer, cardiovascular diseases, or diabetes.
Not a fit: Patients with conditions unrelated to lipid metabolism or those who do not have any metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and treatments for diseases associated with altered lipid metabolism.
How similar studies have performed: Previous research in mass spectrometry-based lipidomics has shown promise, indicating that this approach could yield significant advancements in understanding lipid-related diseases.
Where this research is happening
College Station, United States
- Texas A&m University — College Station, United States (Active)
Researchers
- Principal investigator: Yan, Xin — Texas A&m University
- Study coordinator: Yan, Xin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.